Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis
Abstract Background The incidence and mortality of melanoma is increasing around the world. To deeply explain the mechanism insight into it, we conducted a systematic analysis to examine the levels of regulatory genes of the common RNA epigenetic modification-N6-methyladenosine (m6A) in patients wit...
Main Authors: | Tengda Li, Mingli Gu, Anmei Deng, Cheng Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-020-01309-5 |
Similar Items
-
YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer
by: Kazuo Tsuchiya, et al.
Published: (2021-01-01) -
Research Progress on Relation Between YTHDF1 and Tumors
by: XIAO Shiwei, et al.
Published: (2020-09-01) -
Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation
by: Joseph-Patrick W. E. Clarke, et al.
Published: (2021-03-01) -
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
by: Jian Hu, et al.
Published: (2021-05-01) -
PBRM1 Cooperates with YTHDF2 to Control HIF-1α Protein Translation
by: Alena Shmakova, et al.
Published: (2021-06-01)